| Schedule of other reserves |
Schedule
of other reserves
| (US dollars in thousands) | |
Equity instruments
1 | | |
Preference
shares
1 | | |
Shares
pending
issue
2 | | |
Capital
raising
costs
3 | | |
Equity
incentive
costs
4 | | |
Share
awards
issuance
4 | | |
Foreign
exchange | | |
Total | |
| At June 30, 2021 | |
| - | | |
| 3,270 | | |
| 20,466 | | |
| (8,828 | ) | |
| 1,422 | | |
| (971 | ) | |
| (45 | ) | |
| 15,314 | |
| Issuance of shares | |
| - | | |
| - | | |
| (20,466 | ) | |
| - | | |
| - | | |
| - | | |
| - | | |
| (20,466 | ) |
| Share issuance costs | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | | |
| (1,879 | ) | |
| - | | |
| (1,879 | ) |
| Capital raising costs | |
| - | | |
| - | | |
| - | | |
| (122 | ) | |
| - | | |
| - | | |
| - | | |
| (122 | ) |
| Equity incentives cost less shares issued | |
| - | | |
| - | | |
| - | | |
| - | | |
| 1,452 | | |
| - | | |
| - | | |
| 1,452 | |
| Other movements | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | | |
| (283 | ) | |
| (283 | ) |
| At June 30, 2022 | |
| - | | |
| 3,270 | | |
| - | | |
| (8,950 | ) | |
| 2,874 | | |
| (2,850 | ) | |
| (328 | ) | |
| (5,984 | ) |
| Interest on equity instruments | |
| - | | |
| 198 | | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | | |
| 198 | |
| Equity instruments payments | |
| - | | |
| (149 | ) | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | | |
| (149 | ) |
| Capital raising costs | |
| - | | |
| - | | |
| - | | |
| (446 | ) | |
| - | | |
| - | | |
| - | | |
| (446 | ) |
| Equity incentives cost less shares issued | |
| - | | |
| - | | |
| - | | |
| - | | |
| 147 | | |
| (154 | ) | |
| - | | |
| (7 | ) |
| Other movements | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | | |
| (104 | ) | |
| (104 | ) |
| At June 30, 2023 | |
| - | | |
| 3,319 | | |
| - | | |
| (9,396 | ) | |
| 3,021 | | |
| (3,004 | ) | |
| (432 | ) | |
| (6,492 | ) |
| 1 | | Equity
instruments held at June 30, 2020 were convertible preference shares and convertible
loan notes in Aevitas Group which must convert to shares of VivoPower at $10.20
per
share no later than June 30, 2021. The Company classified these instruments
as equity under the “fixed-for-fixed” rule meaning that both the amount of consideration
received/receivable and the number of equity instruments to be issued is fixed. |
| | | |
| 2 | | During the year
ended June 30, 2021, $20.5 million was recognized in equity for the 2,005,190 restricted Ordinary Shares pending issuance at a
contracted conversion price of $10.20 per share. The 2,005,190 restricted Ordinary Shares were issued on July 21, 2021. |
| 3 | | The $0.4 million
of transaction costs incurred in the year ended June 30, 2023 (year ended June 30, 2022: $0.1 million; year ended June
30, 2021: $2.8 million) relate primarily to capital raises on Nasdaq. |
| 4 | | During the year
ended June 30, 2023, $0.1 million was expensed towards share incentive awards to employees, directors, and consultants of the
Company under the 2017 Omnibus Incentive Plan (year ended June 30, 2022:$1.9 million). Amounts are expensed at the award
grant price over the vesting period, adjusted for actual quantities upon vesting. Of the expenses recorded, $0.1 million of shares were
delivered to participants (year ended June 30, 2022:$1.9 million). During the years ended June 30, 2022 and June 30,
2023, the following awards under the Incentive Plan have been granted, and have vested or forfeit: |
There
were 2,473,367 convertible preference shares outstanding with a face value of AU$3.00 per share and a value held in reserves of AU$11,059,348
at June 30, 2020, representing their face value plus dividends accrued. Convertible preference shares were subordinated to all
creditors of Aevitas Group, ranked equally amongst themselves, and ranked in priority to Ordinary Shares of Aevitas Group.
There
were 2,473,367 convertible loan notes outstanding with a face value of AU$7.00 per share and a value held in reserves of AU$25,075,203,
representing their face value plus the dividends accrued. The convertible loan notes ranked equally with the unsecured creditors of Aevitas
Group.
Dividends
or interest were payable quarterly in arrears at a rate of 7% on the capitalized value to December 29, 2016, the date at which
they became convertible to VivoPower shares. At maturity, or if a trigger event such as a change of control of Aevitas Group or VivoPower,
a listing event, or a disposal of substantially all of the assets of Aevitas Group had occurred, the convertible preference shares and
convertible loan notes in Aevitas Group convert to VivoPower Ordinary Shares at a price of $10.20 per share
On
August 7, 2020, the Company offered one new Aevitas Preference Share, with an issue price of $10, in exchange for each
combined convertible note and convertible preference share, with an issue price of $7 and $3 respectively. Dividends are payable quarterly,
in arrears, at a rate of 7%. Of the 2,473,367 holders of combined convertible note and convertible preference shares, 426,528
holders accepted the terms of the new Aevitas Preference Shares and received 426,528 Aevitas Preference Shares (A$4,265,280) on August
31, 2020, in exchange for the combined convertible notes and convertible preference shares previously held. The new Aevitas Preference
Shares are subordinated to all creditors of Aevitas Group, rank equally amongst themselves, and rank in priority to Aevitas Group Limited
Ordinary Shares for the payment of dividends.
The
426,528 holders which exchanged on August 31, 2020, had earned $26,708 interest on the convertible loan note in the year
ended June 20, 2021, up until exchange, and this was paid in full along with $11,447 dividends that accrued over the same pre-exchange
period on the convertible preference shares. Post-exchange, $185,480 dividends of the Aevitas Preference Shares were earned in the year
ended June 20, 2021, with $121,905 of those paid by June 30, 2021. And the 426,528 Aevitas Preference Shares have a face
value of $3,208,922 (A$10 per share), recognized together with the dividends payable.
On
June 30, 2021, the remaining 2,005,190 holders of convertible preference shares and convertible loan notes in Aevitas Group, exercised
their right to convert the instruments into Ordinary Shares in VivoPower International PLC. The cumulative balance of face value and
accrued unpaid interest and dividends outstanding of the convertible preference shares and convertible loan notes at June 30, 2021
of $20.5 million, was redeemed on that date, and VivoPower International PLC recognized the requirement to issue 2,005,190 restricted
Ordinary Shares, based on a contracted conversion price of $10.20 per share.
| 2 | | During the year
ended June 30, 2021, $20.5 million was recognized in equity for the 2,005,190 restricted Ordinary Shares pending issuance at a
contracted conversion price of $10.20 per share. The 2,005,190 restricted Ordinary Shares were issued on July 21, 2021. |
| 3 | | The $0.4 million
of transaction costs incurred in the year ended June 30, 2023 (year ended June 30, 2022: $0.1 million; year ended June
30, 2021: $2.8 million) relate primarily to capital raises on Nasdaq. |
| 4 | | During the year
ended June 30, 2023, $0.1 million was expensed towards share incentive awards to employees, directors, and consultants of the
Company under the 2017 Omnibus Incentive Plan (year ended June 30, 2022:$1.9 million). Amounts are expensed at the award
grant price over the vesting period, adjusted for actual quantities upon vesting. Of the expenses recorded, $0.1 million of shares were
delivered to participants (year ended June 30, 2022:$1.9 million). During the years ended June 30, 2022 and June 30,
2023, the following awards under the Incentive Plan have been granted, and have vested or forfeit: |
|